0001636050-22-000021.txt : 20220210 0001636050-22-000021.hdr.sgml : 20220210 20220210170732 ACCESSION NUMBER: 0001636050-22-000021 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220208 FILED AS OF DATE: 20220210 DATE AS OF CHANGE: 20220210 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Meswani Parag V CENTRAL INDEX KEY: 0001909324 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37418 FILM NUMBER: 22615189 MAIL ADDRESS: STREET 1: 130 WEST 42ND STREET, 26TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sio Gene Therapies Inc. CENTRAL INDEX KEY: 0001636050 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 853863315 FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 130 WEST 42ND STREET STREET 2: 26TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 BUSINESS PHONE: 877-746-4891 MAIL ADDRESS: STREET 1: 130 WEST 42ND STREET STREET 2: 26TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 FORMER COMPANY: FORMER CONFORMED NAME: Axovant Gene Therapies Ltd. DATE OF NAME CHANGE: 20190516 FORMER COMPANY: FORMER CONFORMED NAME: Axovant Sciences Ltd. DATE OF NAME CHANGE: 20150324 FORMER COMPANY: FORMER CONFORMED NAME: Axovant Sciences, Inc. DATE OF NAME CHANGE: 20150324 4 1 wf-form4_164453082397281.xml FORM 4 X0306 4 2022-02-08 0 0001636050 Sio Gene Therapies Inc. SIOX 0001909324 Meswani Parag V C/O SIO GENE THERAPIES INC. 130 W. 42ND ST., 26TH FL. NEW YORK NY 10036 0 1 0 0 Chief Commercial Officer Restricted Stock Units 2022-02-08 4 A 0 153700 0 A Common Stock 153700.0 153700 D Each restricted stock unit represents the right to receive one share of the Issuer's common stock. One-third of the restricted stock units shall vest on February 8, 2023, February 8, 2024 and February 8, 2025, subject to the Reporting Person providing continuous service to the Issuer through each such date. /s/ David Nassif, Attorney-in-Fact 2022-02-10